The role of the endothelium in hemolytic uremic syndrome

Journal of Nephrology

Volumn 14, Issue 4 SUPPL., 2001, Pages

  Zoja, Carla ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Complement; Endothelium; Leukocytes; Platelets; Verotoxin

Indexed keywords

COMPLEMENT; SHIGA TOXIN;

ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKOCYTE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

COMPLEMENT SYSTEM PROTEINS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LEUKOCYTES; PLATELET ACTIVATION; SHIGA TOXIN;

EID: 0035524167     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60: 831-46.
2. Remuzzi G, Ruggenenti P, Bertani T. Thrombotic microangiopathies. In Tisher, CC, Brenner BM Eds. Renal Pathology. With Clinical and Functional Correlations. Philadelphia: J.B. Lippincott Company 1994; 1154-84.